Georges Naasan, MD

Neurologist

Dr. Georges Naasan is a neurologist who cares for patients with cognitive and behavioral disorders. His focus is neurodegenerative illnesses with dementia. He also provides remote second opinions for patients with various cognitive and behavioral disorders through the UCSF Online Remote Second Opinion Program. He is director of clinical services at the Memory and Aging Center.

As a researcher, Naasan studies hallucinations, delusions and other disturbances in perception arising from neurodegenerative diseases. He also investigates the relationship between neurological conditions and criminal behaviors in older adults.

Naasan earned his medical degree from the American University of Beirut. He completed a residency in neurology at Case Western Reserve University and fellowships in behavioral neurology and neuropsychiatry at UCSF.

Naasan is deeply committed to mentoring health care providers of any discipline who are interested in applying behavioral neurology and neuropsychiatry to their work with patients. He mentors medical students, residents, fellows and international scholars. He is also a faculty member of the Global Brain Health Institute, a partnership between UCSF and Trinity College in Dublin that trains and supports dementia experts on bringing research findings into policy and practice.

Naasan is a member of the American Academy of Neurology. He is an assistant professor of neurology at UCSF.

Clinics

Memory and Aging Center
1500 Owens St., Suite 320
San Francisco, CA 94158
Phone: (415) 353-2057
Fax: (415) 353-8292

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Neurology, American Board of Psychiatry and Neurology

Academic Title

Assistant Professor

More about Georges Naasan

Additional Languages

Arabic

Education

American University of Beirut 2006

Residencies

Case Western Reserve University, Neurology 2011

Fellowships

UCSF, Behavioral Neurology and Neuropsychiatry 2013

Selected Research and Publications

  1. Possin KL, Merrilees J, Bonasera SJ, Bernstein A, Chiong W, Lee K, Wilson L, Hooper SM, Dulaney S, Braley T, Laohavanich S, Feuer JE, Clark AM, Schaffer MW, Schenk AK, Heunis J, Ong P, Cook KM, Bowhay AD, Gearhart R, Chodos A, Naasan G, Bindman AB, Dohan D, Ritchie C, Miller BL. Development of an adaptive, personalized, and scalable dementia care program: Early findings from the Care Ecosystem. PLoS Med. 2017 Mar; 14(3):e1002260.
  2. Naasan G, Rabinovici GD, Ghosh P, Elofson JD, Miller BL, Coppola G, Karydas A, Fong J, Perry D, Lee SE, Yokoyama JS, Seeley WW, Kramer JH, Weiner MW, Schuff N, Jagust WJ, Grinberg LT, Pribadi M, Yang Z, Sears R, Klein E, Wojta K, Rosen HJ. Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase. 2016; 22(1):76-83.
  3. Liljegren M, Naasan G, Temlett J, Perry DC, Rankin KP, Merrilees J, Grinberg LT, Seeley WW, Englund E, Miller BL. Criminal behavior in frontotemporal dementia and Alzheimer disease. JAMA Neurol. 2015 Mar; 72(3):295-300.
  4. Shinagawa S, Naasan G, Karydas AM, Coppola G, Pribadi M, Seeley WW, Trojanowski JQ, Miller BL, Grinberg LT. Clinicopathological Study of Patients With C9ORF72-Associated Frontotemporal Dementia Presenting With Delusions. J Geriatr Psychiatry Neurol. 2015 Jun; 28(2):99-107.
  5. Osman H, Saliba M, Chaaya M, Naasan G. Interventions to reduce postpartum stress in first-time mothers: a randomized-controlled trial. BMC Womens Health. 2014 Oct 15; 14:125.
  6. Naasan G, Irani SR, Bettcher BM, Geschwind MD, Gelfand JM. Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis. JAMA Neurol. 2014 Oct; 71(10):1300-4.
  7. Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, Garcia PA, Miller BL, Mucke L. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013 Sep 01; 70(9):1158-66.
  8. Lamarre AK, Rascovsky K, Bostrom A, Toofanian P, Wilkins S, Sha SJ, Perry DC, Miller ZA, Naasan G, Laforce R, Hagen J, Takada LT, Tartaglia MC, Kang G, Galasko D, Salmon DP, Farias ST, Kaur B, Olichney JM, Quitania Park L, Mendez MF, Tsai PH, Teng E, Dickerson BC, Domoto-Reilly K, McGinnis S, Miller BL, Kramer JH. Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology. 2013 May 21; 80(21):1973-7.
  9. Naasan G, Yabroudi M, Rahi A, Mikati MA. Electroencephalographic changes in pyridoxine-dependant epilepsy: new observations. Epileptic Disord. 2009 Dec; 11(4):293-300.
  10. Mikati MA, Naasan G, Tarabay H, El Yamen S, Baydoun A, Comair YG. Intracarotid propofol testing: a comparative study with amobarbital. Epilepsy Behav. 2009 Mar; 14(3):503-7.
  11. Habib Z, Mourani C, Naasan G, Hourani-Rizk R, Mikati MA. Venous sinus thrombosis in a renal transplant patient. Transplantation. 2007 Mar 27; 83(6):825-7.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.